Press release
Global Arterial Stents Market to Expand Twofold, Reaching a Value of US$ 17,887.9 Mn by 2025
Rising incidences of cardiovascular diseases has prompted people to seek timely treatment to improve life expectancies. Amongst all cardiovascular diseases, coronary heart disease accounts for maximum fatalities annually, claims the American Heart Association (AHA). Increased burden of cardiovascular diseases has compelled patients to seek new trends in treatment.Click here to Get Synopsis of the Report - https://www.factmr.com/report/4713/arterial-stents-market
In the wake of this, the demand for minimally invasive surgical procedures has accelerated. Stents are the most preferred method for correcting cardiac anomalies in this respect. This is because the insertion of stents prevents restenosis. Therefore, the arterial stents market is poised to expand impressively at a CAGR of 9.8% during the forecast period (2020-2025).
Key Trends from the Arterial Stents Market Study:
• Coronary Stents shall dominate the arterial stents market. This is because of an increasing number of coronary artery disease patients and affordability of coronary stents. Anticipated market share is three-fifths of the overall market, growing almost twofold during the forecast period.
• Simultaneously, the Femoral & Popliteal Artery segment is set to experience robust growth. This is attributed to growing Percutaneous Coronary Intervention (PCI) procedures in correcting heart ailments. An impressive 10.2% CAGR is projected for this segment.
For detailed insights on enhancing your product footprint, request for a sample here - https://www.factmr.com/connectus/sample?flag=S&rep_id=4713
• Europe is anticipated to dominate the arterial stents market owing to strategic presence of key market players in the interventional cardiology market. An impressive 9.6% CAGR is projected for the region. Moreover, majority of the patients here opt for coronary artery stents, due to a high number of PCI procedures.
• Asia-Pacific is not very far behind, registering a healthy CAGR of 10.3% during the forecast period. Market penetration by important players and affordability of stents is projected to drive the growth of the region. Coronary Stents are anticipated to hold more than three-fifths of the arterial stents market.
• Downsizing of production of arterial stents is anticipated, owing to the spread of the COVID-19 pandemic. Rising infection rates have shifted priority towards addressing patients with COVID-19. This has relegated non-emergency procedures to the backyard, creating a backlog of cardiac patients. However, cardiac complications arising due to the COVID-19 infection such as arrhythmia and tachycardia will be given top priority.
• Important players such as Boston Scientific Corporation have been contributing significantly to mitigate the spread of the disease. The company has taken significant steps to reduce costs by optimizing manufacturing and output prices and reduction in discretionary spending. It has also undertaken monetary and supply donations along with provision of manufacturing expertise and resources.
For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4713
“The arterial stents market is projected to embark on a positive growth trajectory, driven primarily by increased demand for minimally invasive surgical procedures. To that end, manufacturers are concentrating heavily on product development and expansion of their portfolio,” concludes a Fact.MR analyst.
Market Players Resort to Product Distribution to Expand Market Share
Highly fragmented, the arterial stents market is dominated by more than 50 players. Out of these, three key players- Medtronic, Abbott Laboratories and Boston Scientific Corporation- account for three-tenth of the market share.
Boston Scientific Corporation is the leading player. Its product categories include coronary intervention and peripheral intervention. It specializes in Drug-eluting stents such as Epic, Express & Innova, Self-expanding Stents such as Synergy, Eluvia and Flexive and Bare Metal Stents like Rebel & Promus.
For in-depth competitive analysis, buy now - https://www.factmr.com/checkout/4713/S
Abbott Laboratories, through its Abbott Vascular branch, offers a broad range of endovascular devices and cardiovascular stents. The products it manufactures include Xience Alpine and Xience Xpedition, which are Drug-eluting and Bare Metal Stents respectively, Absolute Pro and Omnilink which are Self-Expanding Stents and RX Acculink which is a Balloon-expanding Stent.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/4713/arterial-stents-market
Content Source: https://www.factmr.com/media-release/1460/global-arterial-stents-market
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Arterial Stents Market to Expand Twofold, Reaching a Value of US$ 17,887.9 Mn by 2025 here
News-ID: 2265674 • Views: …
More Releases from Fact.MR
Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB L …
Digital Twin Market is valued at USD 5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 34.3%, reaching USD 95 billion by 2033. This explosive growth is driven by the increasing adoption of digital twins across industries to optimize operations, reduce costs, and enhance decision-making through virtual replicas of physical assets. Digital twins integrate IoT, AI, and data analytics to simulate real-world…
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 …
The global hemato oncology testing market is valued at USD 4.33 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 18.5%, reaching USD 23.64 billion by 2033. This rapid growth is driven by the increasing prevalence of blood-related cancers, such as lymphoma and leukemia, and advancements in diagnostic technologies like next-generation sequencing (NGS) and polymerase chain reaction (PCR). Hemato oncology testing plays a…
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 203 …
Osseointegration Implants Market is poised for robust growth, with its valuation projected to rise from USD 3.17 billion in 2025 to USD 6.85 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8%. This expansion is driven by the increasing prevalence of orthopedic and dental disorders, such as osteoarthritis, rheumatoid arthritis, and edentulism, which necessitate advanced implant solutions. Osseointegration implants, which fuse directly with bone to provide stable…
Fibrin Sealants Market is Anticipated to Reach USD 1.92 Billion by 2033 | Fact.M …
The global fibrin sealants market is valued at USD 976.5 million in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 7%, reaching USD 1.92 billion by 2033. This growth is driven by the increasing prevalence of surgical procedures requiring effective hemostasis and tissue sealing, particularly in cardiovascular, orthopedic, and general surgeries. Fibrin sealants, derived from human plasma proteins, mimic the body's natural clotting process,…
More Releases for Stent
Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage
An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period.
The future outlook for the airway stent lung…
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion.
Market Revenue Growth
The global airway stent/lung stent market is on an…
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the…
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire…
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp …
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some of…
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients…
